Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Royal Jelly Supplementation on Inflammation and Cellular Senescence in Chronic Kidney Disease Patients Under Hemodialysis

NCT06438445 is registered in ClinicalTrials.gov with Universidade Federal Fluminense as lead sponsor.

NCT NCT06438445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06438445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Royal Jelly Supplementation on Inflammation and Cellular Senescence in Chronic Kidney Disease Patients Under Hemodialysis
Lead sponsor
Universidade Federal Fluminense
Phase
Not applicable
Overall status
Recruiting
Start date
July 30, 2024
Completion date
April 5, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis, kidney failure, chronic, oxidative stress